Flagship Ventures Fund IV, L.P., 10% Owner at Eleven Biotherapeutics, Inc. (EBIO), sold 247,741 shares at $4.51 ($1.1M) on 2016-09-07, disclosed to the SEC on 2016-09-08.
Open-market sale of $1.1M EBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.63 | 3,108 | $14K | 1.3% |
| 2 | $4.63 | 12,441 | $58K | 5.1% |
| 3 | $4.63 | 12,441 | $58K | 5.1% |
| 4 | $4.63 | 20,221 | $94K | 8.3% |
| 5 | $4.63 | 20,221 | $94K | 8.3% |
| 6 | $4.51 | 8,145 |
| $37K |
| 3.3% |
| 7 | $4.51 | 32,597 | $147K | 13.1% |
| 8 | $4.51 | 32,597 | $147K | 13.1% |
| 9 | $4.51 | 52,985 | $239K | 21.2% |
| 10 | $4.51 | 52,985 | $239K | 21.2% |
| Total | $4.54 avg | 247,741 | $1.1M | 100% |